Suzanne Ildstad
No más puestos en curso
Fortuna: 12 M $ al 31/03/2024
Perfil
Suzanne T.
Ildstad is the founder of Talaris Therapeutics, Inc. which was founded in 2002.
She held the title of Chief Scientific Officer & Director from 2018 to 2022.
Dr. Ildstad is also the founder of the University of Louisville.
She received her undergraduate degree from the University of Minnesota.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
1.98% | 14/06/2023 | 507 980 ( 1.98% ) | 12 M $ | 31/03/2024 |
Antiguos cargos conocidos de Suzanne Ildstad.
| Empresas | Cargo | Fin |
|---|---|---|
| University of Louisville | Founder | - |
| TOURMALINE BIO, INC. | Chief Executive Officer | 01/11/2018 |
Formación de Suzanne Ildstad.
| University of Minnesota | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talaris Therapeutics, Inc. is a late-clinical stage cell therapy company, which engages in the development of allogeneic hematopoietic stem cell transplantation. The company was founded by Suzanne Ildstad on February 15, 2002 and is headquartered in Wellesley, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Suzanne Ildstad
